Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
Guisado-Vasco et al., eClinicalMedicine, doi:10.1016/j.eclinm.2020.100591
https://c19hcq.org/guisadovasco.html